FACTOR VIII DEFICIENCY
Clinical trials for FACTOR VIII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new FACTOR VIII DEFICIENCY trials appear
Sign up with your email to follow new studies for FACTOR VIII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot may heal joints in hemophilia a patients
Disease control Recruiting nowThis study looks at whether a once-weekly drug called efanesoctocog alfa can reduce swelling in the joints of people with hemophilia A. About 35 participants aged 12 and older with moderate to severe hemophilia A and existing joint swelling will receive the drug for 12 months. Do…
Matched conditions: FACTOR VIII DEFICIENCY
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Massive study tracks Real-World safety of blood disorder therapies
Knowledge-focused Recruiting nowThis study follows 3,000 people with non-cancer blood disorders (like hemophilia, sickle cell disease, and clotting issues) to see how well treatments work over time and what side effects may occur. Researchers collect safety data on approved therapies to understand long-term ris…
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC
-
Massive european study tracks hemophilia kids for decades
Knowledge-focused Recruiting nowThis study collects health information from 4,000 children with hemophilia A or B across Europe. Researchers track bleeding episodes, joint damage, and antibody development to improve future treatments. The goal is to understand what affects long-term outcomes, not to test a new …
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: PedNet Haemophilia Research Foundation • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC